DoJ extends Biomet DPA
The US Department of Justice (DoJ) extended a foreign bribery deferred prosecution agreement with pharmaceuticals company Biomet for a year in March 2015, the company announced in a US Securities and Exchange Commission filing.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.